David A. Ramsay

Chief Financial Officer, Halozyme Therapeutics.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 30, 2026Shares withheld for tax 5,408 shares at $78.27 of Halozyme Therapeutics⁶
Jun 30, 2026Exercised options 10,000 shares of Halozyme Therapeutics⁶
Dec 19, 2025Sold 20,000 shares at $6.06 of Savara Inc⁵
Dec 9, 2025Granted 40,000 shares of Savara Inc⁸
Mar 31, 2025Bought 150,000 shares at $2.78 of Savara Inc⁹
Dec 12, 2024Granted 40,000 shares of Savara Inc¹⁰
Nov 18, 2024Bought 100,000 shares at $2.88 of Savara Inc¹¹
Dec 14, 2023Granted 22,500 shares of Savara Inc¹²
May 26, 2023Bought 37,124 shares at $2.63 of Savara Inc¹³
May 25, 2023Bought 12,876 shares at $2.57 of Savara Inc¹³
May 24, 2023Bought 50,000 shares at $2.56 of Savara Inc¹³
Dec 30, 2022Bought 29,000 shares at $1.55 of Savara Inc¹⁴
Dec 29, 2022Bought 7,000 shares at $1.54 of Savara Inc¹⁴
Dec 28, 2022Bought 3,293 shares at $1.50 of Savara Inc¹⁵
Dec 23, 2022Bought 15,707 shares at $1.44 of Savara Inc¹⁵
Dec 22, 2022Bought 41,414 shares at $1.48 of Savara Inc¹⁶
Dec 20, 2022Bought 13,830 shares at $1.50 of Savara Inc¹⁷
Dec 20, 2022Bought 3,586 shares at $1.48 of Savara Inc¹⁶
Dec 19, 2022Bought 40,719 shares at $1.49 of Savara Inc¹⁷
Dec 16, 2022Bought 341 shares at $1.50 of Savara Inc¹⁷
Nov 23, 2022Bought 4,610 shares at $1.44 of Savara Inc¹⁸
Nov 22, 2022Bought 15,495 shares at $1.42 of Savara Inc¹⁸
Nov 21, 2022Bought 25,005 shares at $1.42 of Savara Inc¹⁹
Nov 18, 2022Bought 16,100 shares at $1.34 of Savara Inc¹⁹
Nov 17, 2022Bought 8,900 shares at $1.27 of Savara Inc¹⁹

The numbers on this page point here. Each one links to the record it came from.